PMID- 30580504 OWN - NLM STAT- MEDLINE DCOM- 20190415 LR - 20190415 IS - 0304-4920 (Print) IS - 0304-4920 (Linking) VI - 61 IP - 6 DP - 2018 Dec 31 TI - Exploration of Niflumic Acid's Action on Ca(2)(+) Movement and Cell Viability in Human Osteosarcoma Cells. PG - 341-348 LID - CJP.2018.BAH635 [pii] LID - 10.4077/CJP.2018.BAH635 [doi] AB - Niflumic acid, a drug used for joint and muscular pain, affected Ca(2)(+) signaling in different models. However, the effect of niflumic acid on Ca(2)(+) homeostasis and Ca(2)(+)-related physiology in human osteosarcoma cells is unknown. This study examined the effect of niflumic acid on cytosolic free Ca(2)(+) concentrations ([Ca(2)(+)]i) in MG63 human osteosarcoma cells. Intracellular Ca(2)(+) concentrations in suspended cells were monitored by using the fluorescent Ca(2)(+)-sensitive dye fura- 2. Cell viability was examined by using 4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio- 1,3-benzene disulfonate] water soluble tetrazolium-1 (WST-1). In MG63 cells, niflumic acid at concentrations of 250-750 muM evoked [Ca(2)(+)]i rises concentration-dependently. Niflumic acid-evoked Ca(2)(+) entry was confirmed by Mn(2)(+)-induced quenching of fura-2 fluorescence. This entry was inhibited by nifedipine, econazole, SKF96365, the protein kinase C (PKC) activator phorbol 12-myristate 13 acetate (PMA), but was not affected by the PKC inhibitor GF109203X. In Ca(2)(+)- free medium, treatment with the endoplasmic reticulum Ca(2)(+) pump inhibitor thapsigargin (TG) inhibited niflumic acid-evoked [Ca(2)(+)]i rises. Conversely, treatment with niflumic acid abolished TG-evoked [Ca(2)(+)]i rises. Inhibition of phospholipase C (PLC) with U73122 also partly reduced niflumic acid-evoked [Ca(2)(+)]i rises. Niflumic acid killed cells at 200-500 muM in a concentration-dependent fashion. Chelating cytosolic Ca(2)(+) with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid/ AM (BAPTA/AM) did not reverse niflumic acid-induced cytotoxicity. Collectively, our data suggest that in MG63 cells, niflumic acid induced [Ca(2)(+)]i rises by evoking PLC-dependent Ca(2)(+) release from the endoplasmic reticulum, and Ca(2)(+) entry via PKC-sensitive store-operated Ca(2)(+) entry. Niflumic acid also induced Ca(2)(+)-independent cell death. FAU - Liao, Wei-Chuan AU - Liao WC AD - Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan, Republic of China. FAU - Chou, Chiang-Ting AU - Chou CT AD - Department of Nursing, Division of Basic Medical Sciences, Chang Gung University of Science and Technology, Chia-Yi 61363, Taiwan, Republic of China. FAU - Liang, Wei-Zhe AU - Liang WZ AD - Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan, Republic of China. AD - Department of Pharmacy, Tajen University, Pingtung 90741, Taiwan, Republic of China. FAU - Hao, Lyh-Jyh AU - Hao LJ AD - Department of Metabolism, Kaohsiung Veterans General Hospital Tainan Branch, Tainan 71051, Taiwan, Republic of China. FAU - Kuo, Chun-Chi AU - Kuo CC AD - Department of Nursing, Tzu Hui Institute of Technology, Pingtung 92641, Taiwan, Republic of China. FAU - Lin, Ko-Long AU - Lin KL AD - Department of Rehabilitation, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan, Republic of China. FAU - Wang, Jue-Long AU - Wang JL AD - Department of Rehabilitation, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan, Republic of China. FAU - Jan, Chung-Ren AU - Jan CR AD - Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan, Republic of China. LA - eng GR - VGHKS104-095/Kaohsiung Veterans General Hospital/International GR - VGHKS107-169/Kaohsiung Veterans General Hospital/International PT - Journal Article PL - India TA - Chin J Physiol JT - The Chinese journal of physiology JID - 7804502 RN - 4U5MP5IUD8 (Niflumic Acid) RN - EC 3.1.4.- (Type C Phospholipases) RN - SY7Q814VUP (Calcium) SB - IM MH - Apoptosis MH - *Bone Neoplasms MH - Calcium MH - Calcium Signaling MH - Cell Line, Tumor MH - Cell Survival MH - Humans MH - Niflumic Acid MH - *Osteosarcoma MH - Type C Phospholipases OTO - NOTNLM OT - Ca(2)(+) OT - endoplasmic reticulum OT - human osteosarcoma cells OT - niflumic acid OT - viability COIS- The authors declared no conflicts of interest. EDAT- 2018/12/26 06:00 MHDA- 2019/04/16 06:00 CRDT- 2018/12/25 06:00 PHST- 2018/12/25 06:00 [entrez] PHST- 2018/12/26 06:00 [pubmed] PHST- 2019/04/16 06:00 [medline] AID - CJP.2018.BAH635 [pii] AID - 10.4077/CJP.2018.BAH635 [doi] PST - ppublish SO - Chin J Physiol. 2018 Dec 31;61(6):341-348. doi: 10.4077/CJP.2018.BAH635.